These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11127452)

  • 1. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.
    Laham RJ; Chronos NA; Pike M; Leimbach ME; Udelson JE; Pearlman JD; Pettigrew RI; Whitehouse MJ; Yoshizawa C; Simons M
    J Am Coll Cardiol; 2000 Dec; 36(7):2132-9. PubMed ID: 11127452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial.
    Simons M; Annex BH; Laham RJ; Kleiman N; Henry T; Dauerman H; Udelson JE; Gervino EV; Pike M; Whitehouse MJ; Moon T; Chronos NA
    Circulation; 2002 Feb; 105(7):788-93. PubMed ID: 11854116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia.
    Sato K; Laham RJ; Pearlman JD; Novicki D; Sellke FW; Simons M; Post MJ
    Ann Thorac Surg; 2000 Dec; 70(6):2113-8. PubMed ID: 11156130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapericardial administration of basic fibroblast growth factor: myocardial and tissue distribution and comparison with intracoronary and intravenous administration.
    Laham RJ; Rezaee M; Post M; Xu X; Sellke FW
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):375-81. PubMed ID: 12594706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris.
    Unger EF; Goncalves L; Epstein SE; Chew EY; Trapnell CB; Cannon RO; Quyyumi AA
    Am J Cardiol; 2000 Jun; 85(12):1414-9. PubMed ID: 10856385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease.
    Bush MA; Samara E; Whitehouse MJ; Yoshizawa C; Novicki DL; Pike M; Laham RJ; Simons M; Chronos NA
    J Clin Pharmacol; 2001 Apr; 41(4):378-85. PubMed ID: 11304894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs.
    Rajanayagam MA; Shou M; Thirumurti V; Lazarous DF; Quyyumi AA; Goncalves L; Stiber J; Epstein SE; Unger EF
    J Am Coll Cardiol; 2000 Feb; 35(2):519-26. PubMed ID: 10676703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial.
    Laham RJ; Sellke FW; Edelman ER; Pearlman JD; Ware JA; Brown DL; Gold JP; Simons M
    Circulation; 1999 Nov; 100(18):1865-71. PubMed ID: 10545430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial.
    Lazarous DF; Unger EF; Epstein SE; Stine A; Arevalo JL; Chew EY; Quyyumi AA
    J Am Coll Cardiol; 2000 Oct; 36(4):1239-44. PubMed ID: 11028477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia.
    von Degenfeld G; Raake P; Kupatt C; Lebherz C; Hinkel R; Gildehaus FJ; Münzing W; Kranz A; Waltenberger J; Simoes M; Schwaiger M; Thein E; Boekstegers P
    J Am Coll Cardiol; 2003 Sep; 42(6):1120-8. PubMed ID: 13678941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia.
    Laham RJ; Rezaee M; Post M; Novicki D; Sellke FW; Pearlman JD; Simons M; Hung D
    J Pharmacol Exp Ther; 2000 Feb; 292(2):795-802. PubMed ID: 10640320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution.
    Laham RJ; Rezaee M; Post M; Sellke FW; Braeckman RA; Hung D; Simons M
    Drug Metab Dispos; 1999 Jul; 27(7):821-6. PubMed ID: 10383927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease.
    Udelson JE; Dilsizian V; Laham RJ; Chronos N; Vansant J; Blais M; Galt JR; Pike M; Yoshizawa C; Simons M
    Circulation; 2000 Oct; 102(14):1605-10. PubMed ID: 11015335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramyocardial and intracoronary basic fibroblast growth factor in porcine hibernating myocardium: a comparative study.
    Biswas SS; Hughes GC; Scarborough JE; Domkowski PW; Diodato L; Smith ML; Landolfo C; Lowe JE; Annex BH; Landolfo KP
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):34-43. PubMed ID: 14752410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 protein.
    Fearon WF; Ikeno F; Bailey LR; Hiatt BL; Herity NA; Carter AJ; Fitzgerald PJ; Rezaee M; Yeung AC; Yock PG
    Catheter Cardiovasc Interv; 2004 Mar; 61(3):422-8. PubMed ID: 14988909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution.
    Lazarous DF; Shou M; Stiber JA; Dadhania DM; Thirumurti V; Hodge E; Unger EF
    Cardiovasc Res; 1997 Oct; 36(1):78-85. PubMed ID: 9415275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.
    Lederman RJ; Mendelsohn FO; Anderson RD; Saucedo JF; Tenaglia AN; Hermiller JB; Hillegass WB; Rocha-Singh K; Moon TE; Whitehouse MJ; Annex BH;
    Lancet; 2002 Jun; 359(9323):2053-8. PubMed ID: 12086757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial.
    Kovacic JC; Macdonald P; Feneley MP; Muller DW; Freund J; Dodds A; Milliken S; Tao H; Itescu S; Moore J; Ma D; Graham RM
    Am Heart J; 2008 Nov; 156(5):954-63. PubMed ID: 19061712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts.
    Lutter G; Attmann T; Heilmann C; von Samson P; von Specht B; Beyersdorf F
    Eur J Cardiothorac Surg; 2002 Nov; 22(5):753-61. PubMed ID: 12414042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.
    Sato K; Wu T; Laham RJ; Johnson RB; Douglas P; Li J; Sellke FW; Bunting S; Simons M; Post MJ
    J Am Coll Cardiol; 2001 Feb; 37(2):616-23. PubMed ID: 11216988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.